Kernal Bio Partners with Lilly Gateway Labs to Boost In Vivo Cell Therapy Development

Kernal Biologics Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapy Programs Kernal Biologics, Inc., a venture-backed biotechnology company pioneering transformative therapeutics to program human cells directly inside the body, has announced its official relocation to Lilly Gateway Labs…

Read MoreKernal Bio Partners with Lilly Gateway Labs to Boost In Vivo Cell Therapy Development

Aulos Bioscience to Share Updated Phase 2 Imneskibart (AU-007) Data in Melanoma & NSCLC at SITC 2025

Aulos Bioscience to Present Updated Phase 2 Data for Imneskibart (AU-007) in CPI-Refractory Melanoma and NSCLC at SITC 40th Annual Meeting Aulos Bioscience, a pioneering immuno-oncology company dedicated to transforming cancer care through the development of innovative immune-activating therapies, has…

Read MoreAulos Bioscience to Share Updated Phase 2 Imneskibart (AU-007) Data in Melanoma & NSCLC at SITC 2025

South Africa Healthcare Industry 2025: 300+ KPIs on Infrastructure, Demographics & Spending

South Africa Healthcare Industry Databook 2025: Comprehensive Analysis Across 300+ KPIs ResearchAndMarkets.com has recently added the “South Africa Healthcare Industry Market Size & Forecast by Value and Volume Across 300+ KPIs – Databook Q2 2025 Update” to its extensive collection…

Read MoreSouth Africa Healthcare Industry 2025: 300+ KPIs on Infrastructure, Demographics & Spending

Generative AI in Healthcare Market 2025–2035: Trends, Growth Drivers, and Forecasts

Generative AI in Healthcare Market 2025–2035: Trends, Growth Drivers, Applications, and Forecasts The global market for generative AI in healthcare is witnessing rapid expansion, with the sector currently valued at approximately USD 3.3 billion and projected to reach USD 39.8…

Read MoreGenerative AI in Healthcare Market 2025–2035: Trends, Growth Drivers, and Forecasts

Neurogene Reports Inducement Equity Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Neurogene Announces Inducement Equity Grants Under Nasdaq Listing Rule 5635(c)(4) Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company committed to developing life-changing genetic medicines for individuals and families affected by rare neurological diseases, today announced that the Compensation Committee of…

Read MoreNeurogene Reports Inducement Equity Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Presto Dental Opens First Multi-Specialty Clinic in Bridgeport, Expanding Abra Health in Connecticut

Presto Dental Launches Flagship Multi-Specialty Practice in Bridgeport, CT — Marking Abra Health Group’s Expansion Across Connecticut Presto Dental, a new and innovative dental brand affiliated with the Abra Health Group, proudly announces the grand opening of its first multi-specialty…

Read MorePresto Dental Opens First Multi-Specialty Clinic in Bridgeport, Expanding Abra Health in Connecticut